RecruitingPhase 1NCT05106296

Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer

Studying Ependymoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Theodore S. Johnson
Principal Investigator
Theodore S. Johnson, MD, PhD
Augusta University
Intervention
Indoximod(drug)
Enrollment
37 enrolled
Eligibility
3-25 years · All sexes
Timeline
2022 – 2028

Study locations (1)

Collaborators

Augusta University · CureSearch for Children's Cancer · Rally Foundation for Childhood Cancer Research

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05106296 on ClinicalTrials.gov

Other trials for Ependymoma

Additional recruiting or active studies for the same condition.

See all trials for Ependymoma →

← Back to all trials